Mass General Brigham Ventures LLC
10/20/2026 | Press release | Distributed by Public on 10/20/2026 13:36
Five Mass General Brigham faculty elected to National Academy for Medicine
Five Mass General Brigham faculty elected to National Academy of Medicine for 2026
Published October 20, 2026
Mass General Brigham announced the election of five of its distinguished faculty members to the National Academy of Medicine (NAM) for 2026, one of the highest honors in the fields of health and medicine. Their election recognizes outstanding professional achievement and commitment to service, as well as significant contributions to medical science, health care and public health.
The newly elected members bring NAM's total membership to more than 2,600, which includes more than 200 international members.
Mass General Brigham-affiliated faculty elected to NAM include:
Fabrisia Ambrosio, PhD, investigator, Department of Physical Medication and Rehabilitation at Mass General Brigham and director of the Discovery Center for Musculoskeletal Recovery, at Spaulding Rehabilitation Hospital.
Dr. Ambrosio was recognized for her work in regenerative rehabilitation research that couples the use of cellular bioengineering technologies with physical modalities and exercise to improve health, functioning, and longevity. Her research bridges applied biophysics, stem cell therapies, and basic physiology to enhance tissue repair.
Marcela del Carmen, MD, MPH, president, Massachusetts General Hospitaland president of the Massachusetts General Physician Organization.
Dr. del Carmen was recognized for her work transforming the treatment of ovarian cancer and developing new approaches to reduce illness and death related to gynecologic cancers, as well as her leadership of a major academic medical center.
Anna Greka, MD, PhD, physician-investigator, Department of Medicine at Mass General Brigham.
Dr. Greka was recognized for her work elucidating the molecular basis of kidney and genetic diseases, particularly disorders involving protein trafficking and renal barrier function, and for translating those discoveries into targeted therapies.
Nancy Keating, MD, MPH, physician-investigator, Department of Medicine at Mass General Brigham.
Dr. Keating was recognized for her contributions to improving high-quality, high-value cancer care, including research on alternative payment models, the real-world benefits and harms of cancer treatments, and strategies to improve the recommended use, affordability and adherence of cancer therapies.
Jordan Smoller, MD, ScD, physician-investigator, Department of Psychiatry at Mass General Brigham.
Dr. Smoller was recognized for his leadership in uncovering shared and distinct genomic influences across psychiatric disorders and advancing precision psychiatry, including the use of big data and artificial intelligence to inform clinical decision-making for suicide prevention.
Established as the Institute of Medicine in 1970 by the National Academy of Sciences, the National Academy of Medicine addresses critical issues in health, science, medicine and related policy. NAM works alongside the National Academy of Sciences and National Academy of Engineering to provide independent, objective analysis and advice and help address complex problems and inform public policy decisions.
Mass General Brigham Ventures LLC published this content on October 20, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 20, 2026 at 19:36 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]